Search clinical trials for: hydroxychloroquine placebo

Total 53804 results

Children's Hospital of Fudan University

Recruiting

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Surfactant Dysfunction

China
Cambridge University Hospitals NHS Foundation Trust

Unknown

PROLIFIC ChemoprophylaxisTrial (COVID-19)

COVID-19

United Kingdom
Radboud University Medical Center

Unknown

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Breast Cancer

Netherlands
GeoSentinel Foundation

Unknown

HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial (HERO)

COVID-19 | Prophylaxis | Hydroxychloroquine | Health Care Worker

United States
Ravi Amaravadi, MD

Terminated

The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (PATCH)

COVID-19

United States
Health Institutes of Turkey

Completed

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Covid19

Turkey
Rigshospitalet, Denmark

Recruiting

Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

Recurrent Pregnancy Loss

Denmark
National Institute of Allergy and Infectious Diseases...
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

COVID-19 | SARS-CoV 2

United States
University Hospital, Montpellier

Terminated

Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) (COVIDOC)

Coronavirus Infection | Pneumonia, Viral

France
Assistance Publique - Hôpitaux de Paris

Completed

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus (PREP-COVID)

SARS-CoV-2 Infection

France
Washington University School of Medicine

Terminated

Metabolic Effects of Hydroxychloroquine (MetaHcQ)

Type 2 Diabetes Mellitus

United States
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes

Pre-diabetes

United States
University Hospital, Toulouse

Completed

Hydroxychloroquine in Giant Cell Arteritis

Giant Cell Arteritis

France
University of the Philippines

Withdrawn

The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial

COVID-19

Philippines
Peking University First Hospital

Completed

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Hydroxychloroquine | IgA Patients

China
Abderrahmane Mami Hospital
Eshmoun Clinical Research Center; Datametrix

Withdrawn

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals (COVID_2Pro)

COVID19 | Sars-CoV2 | Prophylaxis | Hydroxychloroquine | Healthcare Worker

Tunisia
Rutgers, The State University of New Jersey
SynaVir

Terminated

A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 (TriACT)

Covid19 | SARS-CoV Infection

United States
Government of Punjab, Specialized Healthcare and...
Harvard School of Public Health (HSPH); Forman Christian College, Pakistan; Services... and other collaborators

Terminated

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds (PEACE)

COVID-19 | Coronavirus Infection | SARS-CoV-2 | Asymptomatic Condition

Pakistan
First Affiliated Hospital Xi'an Jiaotong University

Completed

Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease. (CHANGAN)

Coronary Artery Disease

China
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for COVID-19 (COV-HCQ)

COVID-19, Hydroxychloroquine Sulfate

Germany
Alkarkh Health Directorate-Baghdad

Completed

Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients

IMMUNOTHERAPY

Iraq
Government of Punjab, Specialized Healthcare and...
Services Hospital, Lahore; Mayo Hospital Lahore; Pakistan Kidney and Liver Institute

Terminated

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds (PRECISE)

Covid-19 | Sars-CoV2 | Symptomatic Condition

Pakistan
Sanofi

Terminated

Hydroxychloroquine in Outpatient Adults With COVID-19

Coronavirus Infection

United States, Belgium, France, Netherlands
St. Joseph's Healthcare Hamilton

Withdrawn

Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers (PROVIDE)

Corona Virus Infection

Canada
Elaraby Hospital
Shebin El-Kom Teaching Hospital

Completed

Ivermectin Role in Covid-19 Clinical Trial (IRICT)

Covid19

Egypt
Postgraduate Institute of Medical Education and...

Recruiting

Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 (PEP-CQ)

Covid19 | COVID-19 Prevention

India
University of Utah
Intermountain Health Care, Inc.

Withdrawn

Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

Miscarriage | Recurrent Pregnancy Loss

United States
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Not yet recruiting

Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study (QUIgAN)

IgA Nephropathy

France
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Progressive Disease

United States
Sanofi

Completed

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus

Japan
Pulmoquine Therapeutics, Inc
Rockefeller University

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

Severe Acute Respiratory Syndrome Coronavirus 2

United States
Matthias Griese

Suspended

Hydroxychloroquin (HCQ) in Pediatric Interstitial Lung Disease (ILD) (HCQ-chILD-EU)

Interstitial Lung Disease | Diffuse Parenchymal Lung Disease | Children´s Interstitial Lung Disease

Germany
Sir Mortimer B. Davis - Jewish General Hospital

Withdrawn

Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women (HyPreC)

COVID-19 | Pregnant Women | SARS-CoV-2 | Hydroxychloroquine
Military Hospital of Tunis
Dacima Consulting; UR17DN02 : Autoimmune Diseases Research Unit

Unknown

A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers (COVID-Milit)

COVID19 | Sars-CoV2

Tunisia
Shaheed Zulfiqar Ali Bhutto Medical University

Unknown

Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 (CHEER)

COVID 19

Pakistan
Universitaire Ziekenhuizen KU Leuven

Unknown

Effect of Hydroxychloroquine Sulphate in Healthy Lean Females (PLAQHV)

Obesity
Universitaire Ziekenhuizen KU Leuven

Unknown

Effect of Bitter in Overweight Female Volunteers (PLAQOW)

Obesity
Iterum Therapeutics, International Limited
Waterbury Hospital

Withdrawn

Azithromycin Plus Hydroxychloroquine for COVID-19 Infection

Respiratory Tract Infection Viral

United States
Peng Wang, MD PhD

Completed

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

Solid Tumor

United States
Rutgers, The State University of New Jersey

Withdrawn

Asymptomatic COVID-19 Trial (ACT)

SARS-CoV-2 Infection

United States
University of Michigan
Cures Within Reach

Recruiting

Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)

Retinitis Pigmentosa

United States
University of Oxford

Completed

Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting (COPCOV)

Coronavirus | COVID19 | Acute Respiratory Illnesses

United Kingdom, Zambia, Thailand, Benin, Côte D'Ivoire, Indonesia, Kenya, Mali, Nepal, Pakistan
Hospital do Coracao
Hospital Israelita Albert Einstein; Hospital Sirio-Libanes; Brazilian Research... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) (Coalition-I)

Coronavirus Infections

Brazil
Ole Frobert, MD, PhD
Odense University Hospital; Aarhus University Hospital; Vastra Gotaland Region; Värmland County Council, Sweden and other collaborators

Recruiting

Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI (BioDiaMI)

Myocardial Infarction

Denmark, Sweden
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Sint...

Completed

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)

Lyme Disease | Borrelia Infection

Netherlands
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis (SAIL)

Lymphangioleiomyomatosis

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)

Primary Sjögren's Syndrome (pSS)

France
General and Teaching Hospital Celje

Unknown

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Covid-19

Slovenia
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Immunosuppression | Rheumatism
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil

Search clinical trials for: hydroxychloroquine placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations